A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis ...

Charlotte Wright is living with multiple sclerosis that is leaving her housebound. She fears what disability benefit reforms ...

Patients with unconfirmed MS were excluded according to the diagnostic criteria proposed by McDonald et al.; [14] in addition, subjects with progressive MS courses or with benign MS were not ...

Dr Annalisa Morgan previews discussions on disease-modifying therapies, emerging treatments such as CAR T-cell therapy, and ...

also known as relapsing-remitting MS (RRMS). According to the MS Society, in RRMS people have attacks of new and old symptoms, i.e. a relapse. RRMS is the most common type of multiple sclerosis ...

When news broke in October that an approved cancer therapy had, for the first time, halted the progress of multiple sclerosis (MS), excitement was tangible among clinicians and patient groups.

There are relapsing-remitting and progressive types of MS, but the course is rarely predictable. Researchers still don’t fully understand the cause of MS or why the rate of progression is so ...

Most people with multiple sclerosis (MS) have a type called relapsing-remitting MS (RRMS). It usually starts in your 20s or 30s. One study shows that people who began treatment when their first ...

A low educational status was associated with longer delays before initiating treatment among relapsing-remitting MS patients ...

Vision changes can fully or partially resolve quicker with treatment for a flare-up of relapsing-remitting MS (RRMS). But symptoms can be permanent if you don’t get treatment or if you have a ...